$232.82
+ $4.41 (1.93%)
End-of-day quote: 05/14/2024
NYSE:CRL

Charles River Laboratories International Annual Report

Year Year 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Rev. Revenue
$4.13B $3.98B $3.54B $2.92B $2.62B $2.27B $1.86B $1.68B $1.36B $1.30B $1.17B $1.13B $1.14B $1.13B $1.17B $1.30B $1.23B $1.06B $993.33M $724.22M
GM % Gross Margin %
37.03% 36.79% 37.70% 36.90% 36.82% 37.19% 38.86% 39.14% 39.14% 36.68% 34.24% 35.13% 35.29% 34.91% 36.53% 38.51% 38.86% 38.42% 39.23% 39.87%
OM Operating Margin
15.89% 16.56% 17.73% 15.59% 14.79% 15.10% 16.85% 16.24% 16.87% 14.79% 13.35% 15.55% 15.34% 12.94% 16.17% 19.26% 18.46% 17.78% 18.59% 21.81%
EPS Earnings Per Share
$0.00 $10.67 $11.12 $10.32 $8.13 $6.73 $6.03 $5.27 $4.56 $3.76 $3.46 $2.93 $2.74 $2.56 $1.99 $2.38 $2.89 $2.62 $2.19 $2.29 $1.98
Div. Dividends
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio %
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Sha. Shares
51.34m 50.94m 50.48m 49.77m 48.94m 48.21m 47.4m 47.36m 46.7m 47.33m 47.55m 48.22m 48.88m 56.44m 65.88m 67.05m 68.14m 66.92m 71.96m 65.79m
OCF Operating Cash Flow
$683.90M $619.64M $760.80M $546.58M $480.94M $437.41M $316.27M $314.84M $304.96M $251.05M $207.14M $207.90M $205.28M $169.01M $225.04M $282.73M $288.15M $164.37M $234.55M $184.83M
FCF Free Cash Flow
$346.49M $294.91M $532.03M $380.02M $340.42M $301.09M $235.64M $245.09M $223.11M $195.21M $167.99M $160.47M $157.70M $125.38M $145.19M $84.09M $57.21M $-17.38M $140.03M $140.09M
FCFS Free Cash Flow Per Share
$7.13 $5.80 $10.58 $7.67 $6.99 $6.20 $4.92 $5.52 $5.20 $4.16 $3.52 $3.35 $3.07 $2.02 $2.22 $1.25 $0.85 $-0.25 $2.01 $2.82